The efficacy and safety of anti-tnf a treatment in ankylosing spondylitis patients with late onset compared to those with adult onset; the data from turkbio registry

Uslu, SadettinCan, GerçekCefle, AyşeYılmaz, SemaKocaer, Sinem Burcuİnel, Tuba YüceGülle, SemihKoca, Süleyman SerdarYolbaş, ServetÖztürk, Mehmet AkifŞenel, Sonerİnanç, NevsunDalkılıç, EdizSoysal, ÖzgülTufan, AbdurrahmanAkar, ServetBirlik, MerihSarı, İsmailAkkoç, NurullahÖnen, Fatoş2020-03-262020-03-262019Uslu, S., Can, G., Cefle, A., Yılmaz, S., Kocaer, S. B., İnel, T. Y., Gülle, S., Koca, S. S., Yolbaş, S., Öztürk, M. A., Senel, S., Inanc, N., Dalkılıç, E., Soysal, O., Tufan, A., Akar, S., Birlik, M., Sari, İ., Akkoc, N., Onen, F. (2019). Frı0416 The Efficacy and Safety of Anti-Tnf a Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset; The Data From Turkbio Registry. Annals of the Rheumatic Diseases, 78(Suppl 2), 896.0003-49671468-2060https://dx.doi.org/10.1136/annrheumdis-2019-eular.5405https://hdl.handle.net/20.500.12395/38281Annual European Congress of Rheumatology (EULAR) -- JUN 12-15, 2019 -- Madrid, SPAIN[Abstract not Available]en10.1136/annrheumdis-2019-eular.5405info:eu-repo/semantics/openAccessanti-tnfankylosing spondylitisThe efficacy and safety of anti-tnf a treatment in ankylosing spondylitis patients with late onset compared to those with adult onset; the data from turkbio registryConference Object78896896WOS:000472207102461Q1